Circulating Fibroblast Growth Factor-23 Increases Following Intermittent Parathyroid Hormone (1–34) in Postmenopausal Osteoporosis: Association with Biomarker of Bone Formation

被引：0
|
作者：
Geeta Hampson
机构：
[1] Guy’s and St Thomas’ NHS Foundation Trust,Department of Chemical Pathology/Metabolic Bone Clinic
来源：
Calcified Tissue International | 2011年 / 88卷
关键词：
Osteoporosis; Bone Formation; Bisphosphonates; Teriparatide; Postmenopausal Osteoporosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Circulating Fibroblast Growth Factor-23 Increases Following Intermittent Parathyroid Hormone (1–34) in Postmenopausal Osteoporosis: Association with Biomarker of Bone Formation
    M. Sridharan
    J. Cheung
    A. E. Moore
    M. L. Frost
    W. D. Fraser
    I. Fogelman
    G. Hampson
    Calcified Tissue International, 2010, 87 : 398 - 405
  • [2] Circulating Fibroblast Growth Factor-23 Increases Following Intermittent Parathyroid Hormone (1-34) in Postmenopausal Osteoporosis: Association with Biomarker of Bone Formation
    Sridharan, M.
    Cheung, J.
    Moore, A. E.
    Frost, M. L.
    Fraser, W. D.
    Fogelman, I.
    Hampson, G.
    CALCIFIED TISSUE INTERNATIONAL, 2010, 87 (05) : 398 - 405
  • [3] Circulating Fibroblast Growth Factor 23 Increases Following Intermittent Parathyroid Hormone (1-34) in Postmenopausal Osteoporosis: Association with Biomarker of Bone Formation
    Mahon, James
    Casey, Miriam
    CALCIFIED TISSUE INTERNATIONAL, 2011, 88 (06) : 530 - 530
  • [4] Regulation of circulating fibroblast growth factor-23 by parathyroid hormone in patients with primary hyperparathyroidism
    Kurajoh, Masafumi
    Imanishi, Yasuo
    Kobayashi, Keisuke
    Ishii, Akira
    Nagata, Tomoki
    Inaba, Masaaki
    Miki, Takami
    Nishizawa, Yoshiki
    ENDOCRINE JOURNAL, 2010, 57 : S489 - S489
  • [5] Effects of different 1-34 parathyroid hormone dosages on fibroblast growth factor-23 secretion in human bone marrow cells following osteogenic differentiation
    Tillmann, Frank-Peter
    Hofen, Daniela
    Herten, Monika
    Krauspe, Ruediger
    Jaeger, Marcus
    ORTHOPEDIC REVIEWS, 2014, 6 (02) : 60 - 64
  • [6] Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo
    Rhee, Yumie
    Bivi, Nicoletta
    Farrow, Emily
    Lezcano, Virginia
    Plotkin, Lilian I.
    White, Kenneth E.
    Bellido, Teresita
    BONE, 2011, 49 (04) : 636 - 643
  • [7] Determinants of Fibroblast Growth Factor-23 and Parathyroid Hormone Variability in Dialysis Patients
    Jia, Ting
    Qureshi, Abdul Rashid
    Brandenburg, Vincent
    Ketteler, Markus
    Barany, Peter
    Heimburger, Olof
    Uhlin, Fredrik
    Magnusson, Per
    Fernstrom, Anders
    Lindholm, Bengt
    Stenvinkel, Peter
    Larsson, Tobias E.
    AMERICAN JOURNAL OF NEPHROLOGY, 2013, 37 (05) : 462 - 471
  • [8] Fibroblast growth factor-23 regulates parathyroid hormone and 1α-hydroxylase expression in cultured bovine parathyroid cells
    Krajisnik, Tijana
    Bjorklund, Peyman
    Marsel, Richard
    Ljunggren, Osten
    Akerstrom, Goran
    Jonsson, Kenneth B.
    Westin, Gunnar
    Larsson, Tobias E.
    JOURNAL OF ENDOCRINOLOGY, 2007, 195 (01) : 125 - 131
  • [9] Fibroblast growth factor-23 and parathyroid hormone suppress small intestinal magnesium absorption
    Suksridechacin, Nasisorn
    Thongon, Narongrit
    PHYSIOLOGICAL REPORTS, 2022, 10 (07):
  • [10] Fibroblast Growth Factor-23 and Parathyroid Hormone Are Associated with Post-Transplant Bone Mineral Density Loss
    Kanaan, Nada
    Claes, Kathleen
    Devogelaer, Jean-Pierre
    Vanderschueren, Dirk
    Depresseux, Genevieve
    Goffin, Eric
    Evenepoel, Pieter
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 5 (10): : 1887 - 1892
12345